Medical Analysis

Complement 3 (C3) Laboratory Assessment and Clinical Significance

Complement 3 (C3) is a vital 190 kDa protein, composed of two glycoprotein chains associated through disulphide bonds [1]. It is synthesized by hepatocytes, monocytes, and fibroblasts, maintaining a half-life of 2–3 days [1]. C3 is homologous to C4, with cleavage by C3 convertase resulting in the production of a small 77-amino acid fragment C3a, which acts as a strong anaphylatoxin that can also suppress the polyclonal response of B cells [1, 2]. Complement C3 is a blood test that measures the activity of a specific protein, which is part of the complement system—a group of nearly 60 proteins residing in blood plasma or on the surface of some cells [2].

Activation of Complement Cascade: Understanding Immunological Pathways

The activation of the complement cascade occurs through three primary pathways [2]. The Classical pathway is initiated by an antigen-antibody complex, involving C1, C4, and C2 [2, 5]. The Alternative pathway is triggered by activating surfaces, such as endotoxins, involving C3b and Factor B [2]. The Mannose-Binding Lectin (MBL) Pathway is activated by mannose on pathogen surfaces, involving C4, C2, and MBL-associated serine proteases (MASP-1/-2) [2]. All these pathways converge to form C3 convertase, which splits C3 into C3a (anaphylatoxin) and C3b (opsonic factor) [1, 2]. Further progression involves C5 convertase, leading to C5a (a powerful anaphylatoxin) and eventually the formation of the Terminal Complement Complex (TCC) [2].

Functional Role of C3 in Human Immunity

Complement C3 performs several essential physiological functions:

• Opsonization: C3b binds to pathogen surfaces, significantly enhancing phagocytosis by immune cells [1, 8].

• Inflammation: C3a acts as an anaphylatoxin that triggers mast cell degranulation and releases histamine, thereby increasing vascular permeability [1, 2].

• Formation of C5 Convertase: C3b combines with other complement components to aid in membrane attack complex (MAC) formation [2].

• Immune Complex Clearance: C3b binds to immune complexes, facilitating their removal by macrophages in the spleen and liver [1, 2].

• Enhancement of Adaptive Immunity: C3 fragments interact with B cells and dendritic cells, promoting antibody production and immune regulation [1].

• Host Defense: C3 plays a central role in recognizing and eliminating pathogens through the classical, alternative, and lectin complement pathways [1, 8].

Complement 3 Pathophysiology and Clinical Correlations

Complement is a system of plasma proteins activated directly by pathogens or indirectly by pathogen-bound antibodies, leading to a cascade of reactions on the pathogen surface that generates active components with various effector functions [2]. Beyond immediate infection defense, C3 contributes to the development and pathogenesis of hypertension, several cardiovascular and renal diseases, and cardiometabolic disorders accompanied by inflammation and tissue remodeling [10].

Diagnostic Indications and Methodology

Clinical Indications for Testing

Healthcare providers utilize C3 testing for several specific conditions:

• Recurrent pyogenic bacterial infections [3, 4].

• Autoimmune diseases, such as Systemic Lupus Erythematosus (SLE) [5, 6].

• Post-surgical patient monitoring [1].

• Evaluation of infants with suspected deficiencies [4, 7].

• Rheumatoid vasculitis management [6].

• Post-streptococcal glomerulonephritis [5, 6].

• Monitoring therapeutic treatment efficacy [6].

Laboratory Methods of Estimation

The following techniques are employed for C3 estimation:

• Immunoturbidimetric assays [1].

• ELISA (Enzyme-Linked Immunosorbent Assay) [1, 5].

• Western blotting technique [1].

• Immunonephelometric methods [6].

• Radial Immunodiffusion [7].

• Complement functional assays [3, 4].

Sample Collection and Handling Protocol

To ensure accurate diagnostic results, strict adherence to collection protocols is required:

• Collect 3.0 ml of blood in a plain tube (Red capped) or in a Lithium Heparin tube (Green capped).

• Separate the serum as early as possible after collection.

• If storage or transportation is required, the sample must be maintained in a frozen state.

Clinical Interpretation: Factors Influencing C3 Levels

Increased C3 Levels

Increased levels are often observed during an acute phase response, induced by cytokines such as IL-1, IL-6, and TNF [1]. Other causes include biliary obstruction, focal glomerulosclerosis, post-traumatic states, and post-surgical recovery [1].

Decreased C3 Levels

Decreased levels may indicate genetic primary deficiency, presence in infants, Lupus nephritis, subacute bacterial infections, post-streptococcal glomerulonephritis, Neisseria meningitidis infections, active Systemic Lupus Erythematosus (SLE), various liver diseases, or instances of increased protein turnover [3, 4, 6].

Reference Intervals by Age

Reference ranges derived from standardized pediatric and adult clinical immunology studies [7, 9].

For Non-Medicos: Diagnostic Utility and Comparative Insights

Utility Overview

C3 testing is critical for screening complement deficiencies, diagnosing autoimmune conditions, and monitoring disease progression in illnesses like Lupus nephritis and various glomerulopathies [6]. It serves as an essential tool for identifying immunopathology and differentiating between various renal disorders [5, 6].

Comparative Analysis: C3 vs. C4

Important Diagnostic Limitations

It is important to note that interpreting C3 levels in isolation is difficult and requires correlation with other clinical parameters and laboratory results [6]. Improper handling of blood samples can lead to falsely low C3 results [1]. Furthermore, if a C3 test is performed as part of a total complement activity evaluation, the test should be repeated if abnormally low levels are detected [3].

References:

1. Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P., & Lambris, J. D. (2016). Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense. Immunological Reviews, 274(1), 33–58. https://doi.org/10.1111/imr.12500

2. Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015). Complement System Part I – Molecular Mechanisms of Activation and Regulation. Frontiers in Immunology, 6, 262. https://doi.org/10.3389/fimmu.2015.00262

3. McMurray, J. C., Schornack, B. J., Weskamp, A. L., Park, K. J., Pollock, J. D., Day, W. G., et al. (2024). Immunodeficiency: Complement disorders. Allergy and Asthma Proceedings, 45(5), 305–309. https://doi.org/10.2500/aap.2024.45.240050

4. Bernacchia, A., Ginaca, A., Rotondo, S., Tejada, M. P., & Di Giovanni, D. (2024). Case Report: C3 deficiency in two siblings. Frontiers in Pediatrics, 12, 1424380. https://doi.org/10.3389/fped.2024.1424380

5. Lintner, K. E., Wu, Y. L., Yang, Y., Spencer, C. H., Hauptmann, G., Hebert, L. A., et al. (2016). Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases. Frontiers in Immunology, 7, 36. https://doi.org/10.3389/fimmu.2016.00036

6. Sandhu, V., & Quan, M. (2017). SLE and Serum Complement: Causative, Concomitant or Coincidental? The Open Rheumatology Journal, 11, 113–122. https://doi.org/10.2174/1874312901711010113

7. Davis, C. A., Vallota, E. H., & Forristal, J. (1979). Serum complement levels in infancy: age related changes. Pediatric Research, 13(9), 1043–1046. https://doi.org/10.1203/00006450-197909000-00019

8. Tsoni, S. V., & Weis, J. J. (2009). Complement C3 Plays an Essential Role in the Control of Opportunistic Fungal Infections. Infection and Immunity, 77(11), 5069–5077. https://doi.org/10.1128/iai.00233-09

9. van Beek, A. E., Kamp, A., Kruithof, S., Nieuwenhuys, E. J., Wouters, D., Jongerius, I., et al. (2018). Reference Intervals of Factor H and Factor H-Related Proteins in Healthy Children. Frontiers in Immunology, 9, 1727. https://doi.org/10.3389/fimmu.2018.01727

10. Sun, L. (2025). Associations of Serum Complement Biomarkers With Adverse Clinical Outcomes Among Patients With Ischemic Stroke. Journal of the American Heart Association, 14(3), e046136. https://doi.org/10.1161/JAHA.125.046136

FAQ’s:

• What is C3 blood test?
  It measures the activity of C3 protein, a vital component of the human complement immune system.

• How is C3 test performed?
  It uses methods like immunoturbidimetric, ELISA, or immunonephelometric assays on a serum blood sample.

• What triggers C3 activation?
  It activates through classical, alternative, and lectin pathways triggered by pathogens, antibodies, or specific surface molecules.

• Why are C3 levels low?
  Low levels can indicate genetic deficiency, SLE, glomerulonephritis, or severe bacterial infections.

• When are C3 levels high?
  High levels occur during acute inflammatory responses, biliary obstruction, or post-surgical recovery states.

• What does C3 deficiency cause?
  It can lead to recurrent pyogenic bacterial infections and increased susceptibility to opportunistic pathogens.

• How is the sample collected?
  Collect 3.0 ml blood in a plain or lithium heparin tube and freeze the separated serum.

• C3 vs C4 test differences?
  C3 is central to all pathways, while C4 primarily functions in the classical and lectin pathways.

• What is C3’s main role?
  It functions in pathogen opsonization, promoting inflammation, and facilitating the clearance of immune complexes.

• Can C3 monitor autoimmune diseases?
  Yes, it is essential for monitoring activity and disease progression in conditions like SLE and nephritis.

Related Diagnostic Tests

• Complement 4 (C4)